The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

The first draft guidance provides an initial framework for how the agency will assess AI models in drug development, but the ...

New directive scraps Biden-era restrictions and accelerates AI innovation to bolster national security and economic growth.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Among his first actions as president, Donald Trump has rescinded an executive order signed during the Biden administration ...

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals for 2025.

Proprio announced today that it entered into a strategic partnership with LifeHealthcare to distribute its AI surgical ...

DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MDAI) (“” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...